Zhejiang Hisun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DONEPEZIL HYDROCHLORIDE USP, with a corresponding US DMF Number 26605.
Remarkably, this DMF maintains an Active status since its submission on December 27, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 26, 2013, and payment made on December 18, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II